Full 2014 data posted by CMS' Open Payments

Full-year 2014 financial data is now available on the Centers for Medicare & Medicaid Services (CMS) Open Payments website to help consumers better understand financial relationships between physicians and drug and medical device companies. 

The 2014 data includes information on about 11.4 million financial transactions attributed to more than 600,000 physicians and more than 1,100 teaching hospitals, totaling $6.49 billion. Under the Sunshine Act, industry is required annually to report financial interactions with individual physicians to CMS, which the agency makes public through the Open Payments program.

“Consumer access to information is a key component of delivery system reform and making the healthcare system perform better,” said Acting CMS Administrator Andy Slavitt in a release. “In year 2, Open Payments is now a highly searchable resource to provide transparency to over 1 1/2 years’ worth of financial transactions between drug and device companies and physicians and teaching hospitals. This is part of our larger effort to open up the healthcare system to consumers by providing more information to help in their decision making.”

Because the program relies on voluntary participation by physicians and teaching hospitals to review the information submitted by drug and medical device companies there could be some discrepancies. Registered physicians and teaching hospitals reviewed nearly 30 percent of the total value of the reported data but the June 30 data posted on the Open Payments website “also includes a group of 2013 submissions that could not be verified before the first data publication last September, 2014.”

The Open Payments program “has to date been plagued by significant shortcomings that call into question the accuracy of information published, including an overly complex registration process and inadequate opportunity for physicians to review their individual data,” according to the American Medical Association. And, although CMS is required by the Sunshine Act to provide context for data released through the Open Payments program, the agency "has done the bare minimum to comply with the letter of the law." 

According to CMS, 98.8 percent of submitted records in the Open Payments database for all 2014 and 2013 data were validated as containing "accurate identifying information about the associated covered recipient” and those records that “could not be verified to align to an individual covered recipient were rejected and were not processed by the system.”

CMS said it will continue to update the Open Payments website annually with data collected from the previous year and that the agency will refresh and publish an update to the full calendar year of 2014 financial data in early 2016.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.